*Astec Lifesciences Ltd.* | *CMP* Rs. 1397 | *M Cap* Rs. 2737 Cr | *52 W H/L* 1530/901
(Nirmal Bang Retail Research)
*Result is declining*
Revenue from Operations came at Rs. 128.7 Cr (-25.2% QoQ, 14.9% YoY) vs QoQ Rs. 171.9 Cr, YoY Rs. 111.9 Cr
EBIDTA came at Rs. 24.7 Cr (-35.4% QoQ, -12.8% YoY) vs QoQ Rs. 38.2 Cr, YoY Rs. 28.3 Cr
EBITDA Margin came at 19.2% vs QoQ 22.2%, YoY 25.3%
Adj. PAT came at Rs. 13 Cr vs QoQ Rs. 24 Cr, YoY Rs. 16.2 Cr
Quarter EPS is Rs. 6.6
Share is trading at P/E of 34.8x FY22E EPS
(Nirmal Bang Retail Research)
*Result is declining*
Revenue from Operations came at Rs. 128.7 Cr (-25.2% QoQ, 14.9% YoY) vs QoQ Rs. 171.9 Cr, YoY Rs. 111.9 Cr
EBIDTA came at Rs. 24.7 Cr (-35.4% QoQ, -12.8% YoY) vs QoQ Rs. 38.2 Cr, YoY Rs. 28.3 Cr
EBITDA Margin came at 19.2% vs QoQ 22.2%, YoY 25.3%
Adj. PAT came at Rs. 13 Cr vs QoQ Rs. 24 Cr, YoY Rs. 16.2 Cr
Quarter EPS is Rs. 6.6
Share is trading at P/E of 34.8x FY22E EPS